3rd International Conference on CRISPR Technologies
Abstract
As currently defined, CRISPR-Cas technologies facilitate precise genome editing in diverse organisms including prokaryotes, plants, and animals that aims to procure novel developments in various engineering disciplines. The advancement of CRISPR technologies emphasizes the contributions of foundational research to biotechnology broadly. Although the technology is rapidly developing and has been shown to work successfully in numerous organisms, there have been several issues that raised concerns. Many researchers are conducting studies that investigate whether the technique generates stray and possibly precarious genome edits while others are apprehensive that the edited organisms could disrupt entire ecosystems. In order for CRISPR-Cas systems to be used efficiently in a variety of applications, research must be done to increase the specificity of the technology, as well as the methods of delivery of the technologies to living cells. Creating a solution for this issue requires the knowledge of biologists who study the intricacies of these tools and the engineers who commonly use the tools for various practical applications. In this framework we designed the 3rd International Conference on CRISPR Technologies. The first two conferences took place in the US (Raleigh, NC in 2017; San Diego, CA in 2018), and the conference will take place this year for the first time in Europe. Similar to the prior conferences, this year~s conference will serve as a platform for the exchange of ideas between scientists and engineers, and foster collaborations which could greatly improve the efficiency of CRISPR technologies.
Document Details
- Document Type
- DoD Grant Award
- Publication Date
- Sep 30, 2019
- Source ID
- N629091912137
Entities
People
- Richard Taylor
Organizations
- Helmholtz Centre for Infection Research
- Office of Naval Research
- United States Navy